| Regeneron
Sued Novartis In SDNY But Talk Is Of
Northern District and Double Standard
By Matthew
Russell Lee, Patreon
BBC
- Guardian
UK - Honduras
- ESPN
SDNY COURTHOUSE,
Nov 3 – Regeneron
Pharmaceuticals sued Novartis
and Vetter Pharma for
anticompetitive hinderance of
Eylea, its "innovative
biologic drug for the
treatment of severe eye
disease."
On
November 2, U.S. District
Court for the Southern
District of New York Judge
Alison J. Nathan held a
proceeding. Inner City Press
covered it.
Reference was made to a case
in the Northern District of
New York and an attempt to
have cake and eat it too. Any
motion to join additional
parties is due in 30 days.
There have
been no settlement
discussions; the defendants
want to stay discovery.
But another
case management conference is
set for December 10.
The case is
Regeneron Pharmaceuticals Inc.
v. Novartis Pharma AG et al.,
20-cv-5502 (Nathan)
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2020 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com
|
,
